New Agents Push the Envelope in Ovarian Cancer
February 10th 2019Although there have been numerous studies evaluating the role of different therapy schedules, cytotoxic agents, and routes of administration in ovarian cancer, the backbone of therapy remains a combination of a platinum and a taxane.
Read More